LAMEA Dietary Supplements Market By Product (Tablets & Capsules, Powder System, Liquids, Soft Gels), Ingredients (Vitamins & Minerals, Botanicals, Amino Acids, Enzymes & Others), End User (Adults, Children, Infants & Old Aged, Pregnant Woman)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Dietary Supplements Market
The Latin America, Middle East and Africa Dietary Supplements Market would witness market growth of 10.4% CAGR during the forecast period (2017 ? 2023). Growing prevalence of cardiovascular disorders on account of fluctuating diet patterns and inactive lifestyle among the age-group of 30-40 would drive the nutraceuticals market. Awareness about calorie reduction among athletes and gym goers would promote the adoption of supplements within the sports segment. Growing awareness about protein intake, and its benefits would have a huge impact on the market expansion. Awareness about functional foods to remain healthy and reduce the risk of cholesterol related diseases would significantly add to the Dietary Supplements market.
Based on Product, the Dietary Supplements market segments the market into
TABLEts & Capsules, Powder, Liquids, Soft Gels, and Others. Based on Ingredients, the market report segments the market into Vitamins & Minerals, Botanicals, Amino Acids, and Enzymes & Others. Based on End User, the Dietary Supplements market segments the market into Adults, Children, Infants & Old Aged, and Pregnant Woman. Based on Regions, the Dietary Supplements market segments the market into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA. The market research report covers the analysis of key stake holders of the Latin America, Middle East and Africa Dietary Supplements Market.
Key companies profiled in the report include Abbott Laboratories, The Carlyle Group, GlaxoSmithKline plc, Alticor (Amway), Glanbia, Plc. (Glanbia Nutritionals), Bayer AG, Archer Daniels Midland Company, E. I. Du Pont De Nemours and Company, Nutraceutics Inc., and Pfizer, Inc.